CatalystWireBeta

Fundraising of £1.25 Million

In brief · summary, not quotable

Tekcapital raises £1.25 million through placing and subscription at 7 pence per share.

  • Amount raised £1.25 million
  • Placing price per share 7 pence
  • Placing shares issued 17,428,573
  • Subscription shares issued 428,571
  • Total voting shares after admission 234,759,477
Full announcement

Select text to share a quote on X · sign in to keep highlights & notes in your TEK notes

Tekcapital Plc (AIM: TEK) the UK intellectual property investment group focused on creating valuable products that can improve people's lives announces that it has raised a total of £1.25 million (c.US$1.7m) before expenses, in a fundraise (the "Fundraise") comprising of a placing ("Placing") from existing and new shareholders, by way of the issue of, in aggregate, 17,428,573 new ordinary shares of 0.4 pence each in the Company (the "Ordinary Shares"), at a price ("Placing Price") of 7 pence per share (the "Placing Shares"), together with subscriptions ("Subscription") by existing and new shareholders of, in aggregate, 428,571 new Ordinary Shares ("Subscription Shares") at the Placing Price.

The Placing was undertaken by the Company's broker SP Angel Corporate Finance LLP.

Key Highlights:

  • £1.25m (US$1.7m) before expenses was raised by means of the Fundraise.

Funds raised will be deployed as follows:

  • £500,000 will be utilised to enable Guident to rapidly expand its sales staff to onboard additional clients for its Remote Monitor and Control Centre and for costs related to the preparation of Guident's planned IPO in 2025; and
  • the remainder of the funds raised will be used primarily to broaden the Company's GenAI-focused investments and for additional working capital.

Clifford M. Gross Ph.D., Executive Chairman of Tekcapital plc commented:

"On the back of sterling financial performance in 2024, we are pleased to announce the completion of a follow-on raise, which will be allocated to assist Guident in onboarding additional sales support to help manage a large and growing pipeline of business opportunities and for additional working capital. We are actively assessing new GenAI investments, and the remaining proceeds from this fundraise will be allocated to broadening our exposure to the sector, should we identify suitable opportunities. We are bullish about our prospects and believe 2025 is shaping up to be a transformative year for the Company."

Admission and Total Voting Rights

Application will be made for the Placing Shares and the Subscription Shares to be admitted to trading on AIM ("Admission"). It is expected that Admission will become effective on or around 5 June 2025.

Following the issue of the 17,428,573 Placing Shares and the 428,571 Subscription Shares, which, on Admission, will rank pari passu with the existing Ordinary Shares, the total number of Ordinary Shares in issue with voting rights in the Company will be 234,759,477. There are no shares held in treasury.

The above figure of 234,759,477 Ordinary Shares may therefore be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Clifford M. Gross, Ph.D.

SP Angel Corporate Finance LLP (Nominated Adviser and Broker)+44 (0) 20 3470 0470
Richard Morrison/Charlie Bouverat (Corporate Finance)
Richard Parlons/Abigail Wayne (Corporate Broking)
Flagstaff Strategic and Investor Communications+44 (0) 20 7129 1474

Tim Thompson/Andrea Seymour/Fergus Mellon

Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note